Logo

KineMed

KineMed Collaborates With Pfizer on Proteomics Biomarkers

Building on the companies' existing relationship, the deal licenses KineMed's proteomics platform to the pharmaceuticals giant for CDx development.

KineMed, Pronutria Ink R&D Collaboration

The partners will use KineMed's proteomics platform to evaluate the effect of biologics developed by Pronutria for metabolic and other diseases.

In Brief This Week: Agilent Technologies; Diagnocure; KineMed, Pfizer; PositiveID; SomaLogic

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.

KineMed, Pfizer Renew Metabolic Disease Research Collaboration
Premium

NEW YORK (GenomeWeb News) – KineMed this week announced the renewal of its non-exclusive research collaboration with Pfizer into metabolic disease, and type 2 diabetes in particular.

KineMed and CHDI Foundation Extend Collaboration on Huntington's Disease Biomarkers
Premium

NEW YORK (GenomeWeb News) – KineMed said this week that it has extended its collaboration with the CHDI Foundation on research into biomarkers for Huntington's disease.
May 23, 2014

People in the News: Patrick Doyle, Dominique Grau, Jean Halloran
Premium

May 19, 2014

KineMed, CHDI Foundation Extend Huntington's Disease Collaboration

Oct 15, 2013

KineMed Inks Deal with Amgen to Study Brain Proteins Linked to Neurodegenerative Disease

Sep 19, 2013

KineMed Wins $225K SBIR Contract to Develop Myocardial Fibrosis Biomarkers

Aug 23, 2013

People in the News: Thomas Bachmann, Joseph Eggler, and More
Premium

May 21, 2013

KineMed, MedImmune Studying Role of Protein Dynamics in Neurodegenerative Diseases

Mar 27, 2013

KineMed, Pfizer Renew Research Collaboration

Mar 1, 2013

KineMed Inks Pact with Isis and CHDI for Protein Markers for Huntington's Disease
Premium

Feb 21, 2013

Isis, CHDI to Use KineMed Biomarker Platform in Huntington's Disease Effort
Premium

Dec 14, 2012

Myriad RBM Collaborating with Sanofi on Protein Biomarkers for Diabetes Diagnosis, Drug Response
Premium

Jun 27, 2012

KineMed Receives $1.2M from Michael J. Fox Foundation for Parkinson's Biomarkers

Jun 18, 2012

KineMed, GSK Partner on Biomarker Discovery Deal

May 15, 2012

KineMed, CHDI Foundation Collaborate on Huntington's Disease Research

Feb 3, 2012

In Brief This Week: Affymetrix; PerkinElmer; Waters; KineMed, Pfizer; FDA

Feb 3, 2012

KineMed Inks Deal with Pfizer to Use Dynamic Proteomics Platform in Diabetes Drug Development
Premium

Jun 3, 2011

Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
Premium

Mar 11, 2011

KineMed, Bristol-Myers Squibb Extend Collaboration on Alzheimer's Biomarkers
Premium

Mar 9, 2011

KineMed, Bristol-Myers Squibb Extend Collaboration Covering Alzheimer's Disease

Breaking News
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.